Form 4 for CPIX CUMBERLAND PHARMACEUTICALS INC
Accepted 2021-09-10 00:00:00 ET · period of report 2021-08-02 · accession 0001209191-21-055507 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-09-10 | 2021-08-02+ | CPIX | KAZIMI A J | COB, CEO, Dir, 10% | P - Purchase | $2.98 | +315 | 5.77M | +0.0% | +$938.10 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-27 | P | A | 15 | $2.84 | 5,769,114 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 2 | Common | Common Stock | 2021-08-26 | P | A | 15 | $2.82 | 5,769,099 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 3 | Common | Common Stock | 2021-08-31 | P | A | 15 | $2.93 | 5,769,144 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 4 | Common | Common Stock | 2021-08-02 | P | A | 15 | $3.34 | 5,768,844 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 5 | Common | Common Stock | 2021-08-03 | P | A | 15 | $3.17 | 5,768,859 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 6 | Common | Common Stock | 2021-08-04 | P | A | 15 | $3.18 | 5,768,874 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 7 | Common | Common Stock | 2021-08-05 | P | A | 15 | $3.11 | 5,768,889 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 8 | Common | Common Stock | 2021-08-06 | P | A | 15 | $3.01 | 5,768,904 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 9 | Common | Common Stock | 2021-08-09 | P | A | 15 | $2.93 | 5,768,919 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 10 | Common | Common Stock | 2021-08-10 | P | A | 15 | $2.96 | 5,768,934 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 11 | Common | Common Stock | 2021-08-11 | P | A | 15 | $2.98 | 5,768,949 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 12 | Common | Common Stock | 2021-08-13 | P | A | 15 | $2.92 | 5,768,964 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 13 | Common | Common Stock | 2021-08-16 | P | A | 15 | $2.92 | 5,768,979 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 14 | Common | Common Stock | 2021-08-17 | P | A | 15 | $3.05 | 5,768,994 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 15 | Common | Common Stock | 2021-08-18 | P | A | 15 | $2.97 | 5,769,009 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 16 | Common | Common Stock | 2021-08-19 | P | A | 15 | $3.02 | 5,769,024 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 17 | Common | Common Stock | 2021-08-20 | P | A | 15 | $2.96 | 5,769,039 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 18 | Common | Common Stock | 2021-08-23 | P | A | 15 | $2.87 | 5,769,054 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 19 | Common | Common Stock | 2021-08-24 | P | A | 15 | $2.89 | 5,769,069 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 20 | Common | Common Stock | 2021-08-25 | P | A | 15 | $2.79 | 5,769,084 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |
| 21 | Common | Common Stock | 2021-08-30 | P | A | 15 | $2.88 | 5,769,129 | D | — | — | (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021. |